FDA Proposes New Rules for Tobacco Product Manufacturing

Mar.09.2023
FDA Proposes New Rules for Tobacco Product Manufacturing
The FDA proposes new rules for tobacco product manufacturing to protect public health and ensure consistency and reduce contamination.

US regulatory agency will seek input from advisory committees and the general public regarding proposed regulations.


The United States Food and Drug Administration (FDA) has proposed new requirements for the manufacturing, design, packaging, and storage of electronic cigarettes and other tobacco products. The proposed regulations aim to protect public health, minimize or prevent contamination, limit additional risks, and ensure product consistency.


The proposed regulations apply to manufacturers of both finished and bulk electronic cigarettes and other tobacco products. Under the proposed rules, finished tobacco products refer to any component or part of a tobacco product that is packaged in the final packaging, such as electronic cigarettes, cigarette packaging, or wet tobacco cans. Bulk tobacco products refer to tobacco products that are not packaged in the final packaging but are suitable for consumer use.


This proposed new regulation will be beneficial for manufacturers.


Adhere to the Federal Food, Drug and Cosmetic Act and take measures to minimize or prevent contamination in tobacco products, such as metals, glass, and plastics.


Solution to the problem of inconsistency between electronic cigarette e-liquid product labels and actual concentration.


3. Establish requirements related to identification, traceability, and correction of tobacco products that do not meet specifications or have been contaminated, including those already distributed.


If issues arise, these regulations will require manufacturers to take corrective action, which might include initiating a recall.


The proposed rules establish a framework for manufacturers to comply with, which includes:


Establish a mechanism for controlling the design and development of tobacco products.


B. Ensure that the production of finished and loose tobacco products meets established standards.


C. Aim to minimize the production and distribution of tobacco products that do not meet industry standards.


D. It is demanded that manufacturers must take appropriate measures to prevent contamination of tobacco products.


Demanding an investigation and identification of non-compliant products in order to take appropriate corrective measures such as recalling them.


Establish the ability to track all components, parts, ingredients, additives, and materials, as well as each batch of finished or loose tobacco products, in order to assist in investigating those products that do not meet the specifications.


The FDA will hold a public hearing on April 12 to collect opinions from various stakeholders, including the industry, scientific community, advocacy groups, and the public. The proposed rules will also be open for public comment for 180 days. The FDA will review all comments.


The FDA will convene a meeting of the Tobacco Products Scientific Advisory Committee (TPSAC) on May 18 to seek recommendations from external expert groups. As part of the TPSAC meeting, the public will have an opportunity to provide verbal statements. The FDA intends to publish TPSAC meeting materials on its website no later than 48 hours before the meeting begins.


2FIRSTS will conduct interviews with individuals affected by the new regulations and continue to report on the matter.


Reference:


The U.S. Food and Drug Administration (FDA) has put forward new regulations for the manufacturing of vaping products.


The Food and Drug Administration (FDA) has put forth new regulations regarding the production practices of tobacco products. These requirements aim to improve the manufacturing standards of tobacco products in order to reduce their harmful effects on consumers.


The Proposed Rule titled "Requirements for Tobacco Product Manufacturing Practice" has been introduced.


The Tobacco Products Scientific Advisory Committee (TPSAC) convened for a meeting.


Public hearing to discuss proposed regulations for tobacco product manufacturing practices.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Imperial Brands Expects Low-Single-Digit Tobacco and NGP Net Revenue Growth in H1
Imperial Brands Expects Low-Single-Digit Tobacco and NGP Net Revenue Growth in H1
Imperial Brands released a trading update on April 14, reiterating its FY26 guidance and saying its 2030 transformation has started positively. The company said it still expects low-single-digit tobacco net revenue growth, double-digit NGP net revenue growth, 3.00% to 5.00% growth in Group adjusted operating profit, at least high-single-digit earnings per share growth, and at least GBP 2.2 billion in free cash flow for the full year.
Apr.14 by 2FIRSTS.ai
Japan Tobacco Q1 2026 Financial Results: Revenue at $5.914 Billion,RRP Revenue Up 63.8% YoY
Japan Tobacco Q1 2026 Financial Results: Revenue at $5.914 Billion,RRP Revenue Up 63.8% YoY
Japanese Tobacco (JT) reports Q1 2026 revenue of 924 billion yen, a 15.2% increase; operating profit rises 24.7%.
May.08 by 2FIRSTS.ai
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas says newly released internal FDA records show agency scientific reviewers supported authorization for several flavored G2 products before senior leadership halted them. According to documents obtained through a Freedom of Information Act request, FDA’s Office of Science first recommended marketing authorization for all eight products in December 2025 and later supported six of them in February 2026. FDA ultimately authorized only the G2 device and one tobacco-flavored pod in March.
Apr.23 by 2FIRSTS.ai
Ukrainian Media: Polish Vape Distributor Evapify Allegedly Linked to Russian Businessman Named in U.S. “Russia Oligarch Report”
Ukrainian Media: Polish Vape Distributor Evapify Allegedly Linked to Russian Businessman Named in U.S. “Russia Oligarch Report”
According to an investigative report by Euromaidan Press, a Ukrainian English-language independent media outlet, Russian businessman Oleg Boyko has been sanctioned by Ukraine, Poland, Australia and Canada, but has not been added to the European Union’s sanctions list. The report alleges that Evapify, a Polish vape distributor with financial and personal ties to Boyko, holds a significant position in Poland’s disposable vape market.
News
Jun.01
Thailand’s DDC Reaffirms Nicotine Pouches Are Regulated Under the Tobacco Products Control Act
Thailand’s DDC Reaffirms Nicotine Pouches Are Regulated Under the Tobacco Products Control Act
Thailand’s Department of Disease Control has warned the public not to believe claims that nicotine pouches are harmless, saying the products contain high levels of nicotine that can enter the bloodstream through the mouth lining and affect the nervous system and brain.
Apr.30 by 2FIRSTS.ai
Malaysian Court Rules Liquid Nicotine Exemption Irrational, Renewing Vape Regulation Debate
Malaysian Court Rules Liquid Nicotine Exemption Irrational, Renewing Vape Regulation Debate
Malaysia’s High Court ruled that the government’s earlier decision to remove liquid nicotine from the country’s Poisons List was “irrational,” reigniting debate over vape regulation, illicit trade, and youth protection.
Regulations
May.18